BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 26194683)

  • 21. MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study.
    Chopra S; Engineer R; Shah S; Shukla R; Dora T; Gupta P; Paul SN; Popat P; Swamidas J; Mahantshetty U; Varghese L; Gupta S; Rangrajan V; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):310-319. PubMed ID: 31682968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of 6 fractions of 5.3 Gray HDR brachytherapy in combination with external beam radiotherapy for treatment of cervical cancer.
    Koh WY; Lim K; Tey J; Lee KM; Lim GH; Choo BA
    Gynecol Oncol; 2013 Oct; 131(1):93-8. PubMed ID: 23906655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
    Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?
    Horne ZD; Karukonda P; Kalash R; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Bochmeier MM; Berger JL; Taylor SE; Sukumvanich P; Beriwal S
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):157-164. PubMed ID: 30605752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
    Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix.
    Forrest JL; Ackerman I; Barbera L; Barnes EA; Davidson M; Kiss A; Thomas G
    Int J Gynecol Cancer; 2010 Aug; 20(6):1074-8. PubMed ID: 20683420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical results of combined intracavitary-interstitial image-guided adaptive brachytherapy in locally advanced cervical cancer].
    Vízkeleti J; Fröhlich G; Nhung NA; Horváth K; Major T; Polgár C
    Magy Onkol; 2018 Dec; 62(4):249-257. PubMed ID: 30540868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.
    Qu A; Jiang P; Sun H; Jiang W; Jiang Y; Tian S; Wang J
    J Gynecol Oncol; 2019 Jan; 30(1):e9. PubMed ID: 30479093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
    Vulpe H; Asamoah FA; Maganti M; Vanderpuye V; Fyles A; Yarney J
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1246-1253. PubMed ID: 29395628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.